Myeloperoxidase and plaque vulnerability.
Hazen
Stanley L
SL
D001161:Arteriosclerosis / Q000201:enzymology* / Q000209:etiology / Q000473:pathology; D003328:Coronary Thrombosis / Q000209:etiology; D016757:Death, Sudden, Cardiac / Q000209:etiology; D018450:Disease Progression; D004730:Endothelium, Vascular / Q000473:pathology; D005260:Female; D005978:Glutathione / Q000502:physiology; D006801:Humans; D006997:Hypochlorous Acid / Q000378:metabolism; D018836:Inflammation Mediators / Q000502:physiology*; D008264:Macrophages / Q000201:enzymology; D008297:Male; D008954:Models, Biological; D009195:Peroxidase / Q000502:physiology*; D012422:Rupture, Spontaneous; D019851:Thrombophilia / Q000209:etiology; D013925:Thromboplastin / Q000502:physiology
D018836:Inflammation Mediators; D006997:Hypochlorous Acid; D013925:Thromboplastin; D009195:Peroxidase; D005978:Glutathione